DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Marks WJ, Ostrem JL, Verhagen L. et al.
Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson’s disease: an open-label, phase I trial.
Lancet Neurol 2008; 7: 400-408
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.